Kainos Medicine (XKRX:284620) Other Income (Expense) : ₩615.3 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Kainos Medicine Other Income (Expense)?

Kainos Medicine's other income expense for the Kainos Medicine's pretax income for the three months ended in Mar. 2024 was ₩-28.7 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩615.3 Mil.

Kainos Medicine Other Income (Expense) Historical Data

The historical data trend for Kainos Medicine's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kainos Medicine Other Income (Expense) Chart

Kainos Medicine Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

Get a 7-Day Free Trial

3.13

-2,659.99

-3,420.42

-960.99

604.07

Kainos Medicine Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Expense)	Get a 7-Day Free Trial															33.77	-12.45	610.84	45.59	-28.70

Kainos Medicine Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩615.3 Mil.

Kainos Medicine (XKRX:284620) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Kainos Medicine (XKRX:284620) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kainos Medicine Inc (XKRX:284620) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

16, Daewangpangyo-ro 712 beon-gil, 4th Floor, Institut Pasteur Korea, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13488

Website

http://www.kainosmedicine.com

Kainos Medicine Inc conducts research and develops medicines used to treat brain diseases, cancers, and infectious diseases.

Kainos Medicine (XKRX:284620) Headlines

No Headlines